drugset
drugset / Trial / NCT01790685

Ozurdex for Retinal Vein Occlusion Study (ORVO Study)

NCT01790685 ↗

Phase 2/3 Completed 40 enrolled Johns Hopkins University Allergan · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To measure the pro-permeability factors in the aqueous humor of patients with persistent/recurrent macular edema after an injection of Ozurdex.

Timeline

Start
2013-02
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Other

Indications

retinal vein occlusion